title: High susceptibility of analbuminemic rats to neurogenic tumor induction by transplacental administration of N-ethyl-N-nitrosourea.
abstract: The susceptibilities of Nagase analbuminemic rats (NAR) and control Sprague-Dawley rats (SDR) to N-ethyl-N-nitrosourea (ENU) were compared. In Experiment I, the rats were given daily subcutaneous injections of 10 mg/kg of ENU for a week from 4 weeks of age. In Experiment II, mother rats were given a single subcutaneous injection of 60 mg/kg of ENU on day 17 of pregnancy and tumor development in their offspring was examined. In Experiment I, the incidence of neurogenic tumors was slightly, but not significantly, higher in NAR than in control rats. In Experiment II, the incidence of total tumors including neurogenic tumors was significantly higher in NAR (40/43, 93.0%) than in SDR (13/61, 21.3%). NAR showed particularly high susceptibility to induction of neurogenic tumors (34/43, 79.1%) and renal tumors (15/43, 34.9%). In an attempt to elucidate the underlying mechanisms of the increased susceptibility of NAR to ENU, O6-ethylguanine, a major premutagenic ethylated DNA adduct, was quantitated in fetal brain DNA of NAR and SDR after a pulse exposure to 60 mg/kg ENU. No significant difference in the initial formation or subsequent repair of O6-ethylguanine was observed in the two strains, indicating that abnormality at some later stage(s) of chemical carcinogenesis may lead to the increased susceptibility of NAR to induction of neurogenic tumors.
authors.affiliation: Department of Biochemistry, Sasaki Institute, Tokyo.
authors.forename: S
authors.initials: S
authors.lastname: Usuki
authors.forename: A
authors.initials: A
authors.lastname: Maekawa
authors.forename: H
authors.initials: H
authors.lastname: Kang
authors.forename: S
authors.initials: S
authors.lastname: Shumiya
authors.forename: S
authors.initials: S
authors.lastname: Nagase
mesh_terms: D000818:Animals; D001932:Brain Neoplasms / Q000139:chemically induced* / Q000473:pathology; D004273:DNA, Neoplasm / Q000032:analysis; D004198:Disease Susceptibility; D005038:Ethylnitrosourea / Q000008:administration & dosage*; D005260:Female; D006147:Guanine / Q000031:analogs & derivatives / Q000032:analysis; D007279:Injections, Subcutaneous; D008297:Male; D010920:Placenta; D011247:Pregnancy; D051381:Rats; D011919:Rats, Inbred Strains; D013120:Spinal Cord Neoplasms / Q000139:chemically induced* / Q000473:pathology
chemical_list: D004273:DNA, Neoplasm; D006147:Guanine; D005038:Ethylnitrosourea